M&A Deal Summary

Danaher Acquires Pall

On May 13, 2015, Danaher acquired manufacturer Pall for 13.8B USD

Acquisition Highlights
  • This is Danaher’s 1st transaction in the Manufacturing sector.
  • This is Danaher’s 2nd largest (disclosed) transaction.
  • This is Danaher’s 23rd transaction in the United States.
  • This is Danaher’s 1st transaction in New York.

M&A Deal Summary
Date 2015-05-13
Target Pall
Sector Manufacturing
Buyer(s) Danaher
Deal Type Add-on Acquisition
Deal Value 13.8B USD
Advisor(s) Goldman Sachs (Financial)
Shearman & Sterling (Legal)

Target

Pall

Port Washington, New York, United States
Pall Corp. is a provider of filtration, separation and purification products to meet the critical fluid management needs of customers across the broad spectrum of life sciences and industry.

Search 200,388 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Danaher

Washington, District of Columbia, United States
Category Company
Founded 1969
Sector Diversified
Employees79,000
Revenue 23.9B USD (2023)
DESCRIPTION

Danaher designs, manufactures and markets professional, medical, industrial and commercial products and services. Danaher's research and development, manufacturing, sales, distribution, service and administrative facilities are located in more than 50 countries. Danaher's business consists of five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental; and Industrial Technologies. Danaher was incorporated in 1969 and is based in Washington, District of Columbia.

DEAL STATS #
Overall 32 of 43
Sector (Manufacturing) 1 of 1
Type (Add-on Acquisition) 29 of 39
State (New York) 1 of 1
Country (United States) 23 of 28
Year (2015) 1 of 2
Size (of disclosed) 2 of 23
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-09-15 Nobel Biocare Services AG

Kloten, Switzerland

Nobel Biocare is a world leader in the field of innovative implant-based dental restorations. The company’s portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems (including key brands NobelActive®, Brånemark System® and NobelReplace®), a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems (NobelProcera®), diagnostics, treatment planning and guided surgery solutions (NobelClinician® and NobelGuide®) and biomaterials (creos™). Nobel Biocare supports its customers through all phases of professional development, offering world-class training and education along with practice support and patient information materials. The company is headquartered in Zurich, Switzerland. Production takes place at six sites located in the United States, Sweden, Japan and Israel. Products and services are available in over 80 countries through subsidiaries and distributors.

Buy $2.2B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-07-14 Danaher Corp - Communications Business

United States

Sell $2.3B
Mergr

Product

Company

Legal